formation induced by dopamine D2S receptors via G␤␥-subunits in Balb/c-3T3 cells. Am J Physiol Cell Physiol 284: C640-C648, 2003. First published November 13, 2002 10.1152/ajpcell.00190.2002 and ceramide are important second messengers affecting cell growth, differentiation, and apoptosis. Balb/c-3T3 fibroblast cells expressing dopamine-D2S (short) receptors (Balb-D2S cells) provide a model of G protein-mediated cell growth and transformation. In Balb-D2S cells, apomorphine (EC 50 ϭ 10 nM) stimulated DAG and ceramide formation by 5.6-and 4.3-fold, respectively, maximal at 1 h and persisting over 6 h. These actions were blocked by pretreatment with pertussis toxin (PTX), implicating G i/Go proteins. To address which G proteins are involved, Balb-D2S clones expressing individual PTX-insensitive G␣ i proteins were treated with PTX and tested for apomorphine-induced responses. Neither PTX-insensitive G␣ i2 nor G␣i3 rescued D2S-induced DAG or ceramide formation. Both D2S-induced DAG and ceramide signals required G␤␥-subunits and were blocked by inhibitors of phospholipase C [1-(6-[([17␤]-3-methoxyestra-1,2,3[10]-trien17yl)amino]hexyl)-1H-pyrrole-2,5-dione (U-73122) and partially by D609]. The similar G protein specificity of D2S-induced calcium mobilization, DAG, and ceramide formation indicates a common G␤␥-dependent phospholipase C-mediated pathway. Both D2 agonists and ceramide specifically induced mitogen-activated protein kinase (ERK1/2), suggesting that ceramide mediates a novel pathway of D2S-induced ERK1/2 activation, leading to cell growth. phospholipase C; G protein; mitogen-activated protein kinase THE DOPAMINE-D2 receptor gene encodes two splice variants of the receptor, long and short forms (D2L and D2S), that are pharmacologically and functionally equivalent with both forms coupling equivalently to G i /G o "inhibitory" proteins (10, 28). In pituitary cells, the dopamine D2S receptor inhibits ERK1/2 activation and cell proliferation (1, 13, 32, 37) . Oppositely, in Balb/c-3T3, Chinese hamster ovarian (CHO), and C6 mesenchymal cells, the D2S receptor stimulates cell proliferation and induces tumor formation, involving calcium mobilization and ERK1/2 activation (8, 16, 20, 26, 31) . These actions are blocked by pertussis toxin (PTX), implicating G i /G o proteins. However, the signaling pathways that mediate G i /G o -induced regulation of cell proliferation remain poorly defined.
. These actions are blocked by pertussis toxin (PTX), implicating G i /G o proteins. However, the signaling pathways that mediate G i /G o -induced regulation of cell proliferation remain poorly defined.
Ceramide is a novel and important second messenger involved in a wide variety of signal transduction pathways that mediate cell-specific biological responses such as cell growth, differentiation, inflammation, and apoptosis (11, 12, 19, 22) . Ceramide is produced from many sources, such as the action of sphingomyelinase (SMase) on sphingomyelin (SM) (33) , de novo synthesis (27) , or metabolism of other lipids (7, 17) . There is also a close dynamic relationship between the biosynthetic pathways for diacylglycerol (DAG) and ceramide via SM synthase, which interconverts ceramide/phosphatidylcholine (PC) into SM/DAG (22) . Thus this work focused on the relationship between DAG and ceramide levels and their regulation by D2S receptor activation in signaling to cell proliferation.
To address whether different G proteins mediate divergent D2S-induced responses, we have expressed antisense or PTX-insensitive mutant G␣ i /G␣ o constructs in GH4 pituitary or Balb/c-3T3 fibroblast cells (15, 16, 23, 24) . PTX-insensitive G␣ mutants were generated by a conservative Cys-to-Ser substitution and retain coupling to a variety of effectors (9, 16, 38) , including G␣ i -mediated inhibition of adenylyl cyclase, G␤␥-induced inhibition of calcium channels, and G␤␥-induced ERK1/2 activation. By pretreating cells with PTX to block endogenous G i /G o proteins, the specific contribution of individual G proteins can be assessed in cells transfected with individual PTXresistant G␣ proteins. In Balb-D2S cells (Balb/c-3T3 cells transfected with D2S receptor cDNA), G␣ i2 /G␤␥ mediated D2S-induced ERK1/2 activation and DNA synthesis, and G␣ i3 was required for D2S-induced transformation (16) . These results indicate that whereas ERK1/2 activation is linked to D2S-mediated DNA synthesis, G␣ i3 -dependent signaling to transformation did not require ERK1/2 and utilized unknown messengers. We therefore addressed the question of whether D2S receptor activation regulates other second messengers, such as DAG or ceramide, and which G proteins are required. Cell culture and transfection. Balb-D2S cells and derivative clones were cultured in Dulbecco's modified Eagle's medium (DMEM) plus 10% fetal bovine serum (FBS). Balb-D2S (clone 11) cells were generated as described, and specific D2S receptor density was 143.6 Ϯ 35.9 fmol/mg protein by saturation binding analysis with [ 3 H]spiperone (16) . PTX-insensitive mutant G␣i/G␣o subunit constructs (Gi2-PTX and Gi3-PTX) and GRK-ct were constructed previously (15) and transfected individually (30 g) into Balb-D2S (clone 11), and the cells were selected in medium containing G418 (700 g/ml) for 2-3 wk (16) . Antibiotic-resistant clones of each transfection were picked (24 clones/transfection) and tested for expression of the corresponding G␣i/G␣o proteins using Northern blot and Western blot analyses.
MATERIALS AND METHODS

Materials
Treatment and lipid extraction. Equivalent numbers of cells were cultured in 10 ϫ 10 cm plates with DMEM plus 10% FBS in a humidified atmosphere of 5% CO2 at 37°C, growing to 80-90% confluence. Before experiments, the cells were cultured in serum-free medium for 16 h. For PTX treatment, the cells were treated with 50 ng/ml PTX for 16 h before experimentation. Cells were treated with apomorphine at the designed concentration and time and with S. aureus SMase (0.1 U/ml) for 30 min. After treatment, twice washing with ice-cold phosphate-buffered saline (PBS) terminated the reaction. The lipid extraction method was based on that of Bligh and Dyer (5) . After centrifugation at 500 g for 1 min at 4°C, the supernatants were aspirated and the cells were lysed with 0.5 ml of chloroform-methanol-HCl (20:40:1 vol/vol/vol). Extracts were sonicated each 5 s ϫ 6 times on ice, rinsed with 1 ml of chloroform and 0.3 ml 1 M NaCl, and spun at 14,000 g for 15 min at 4°C. The upper aqueous layer was discarded, and the lower lipid-containing layer was transferred to a 1-ml glass Chrompack vial, dried under a stream of O2-free N2 gas, and redissolved in 200 l of chloroform. The samples were stored at Ϫ80°C until analysis. The particulate protein interface was air-dried, dissolved in 0.5 ml 2 M NaOH, and assayed for protein according to Lowry's method.
Quantitation of DAG and ceramide. DAG and ceramide were quantified in parallel using the DAG kinase method, as described by Preiss et al. (34) and modified by Wright et al. (44) . Briefly, after treatment and solvent extraction of cell lipids, the chloroform of samples was then evaporated under N2. A blank tube and standard ceramide/DAG tubes were included as controls. For each sample, 10 l of DAG kinase (20 mU), 50 l of reaction buffer, 10 l of 20 mM dithiothreitol, and 10 l of [␥-32 P]ATP (2.5 ϫ 10 5 dpm/nmol) were added. Reaction buffer contained 25 mM MgCl2 and 2 mM EGTA dissolved in 50 ml of 100 mM imidazole (pH 6.6), and the pH was readjusted to 6.6. The samples were incubated at 25°C for 30 min, and the reaction was terminated by addition of 0.5 ml of ice-cold chloroform-methanol (1:2 vol/vol). The lipids were extracted by the addition of 0.5 ml chloroform and 0.5 ml 1 M NaCl. The mixture was spun at 14,000 g for 3 min, and the upper aqueous phase was discarded. The lower organic phase was sequentially washed with 0.5 ml of 1% perchloric acid, 0.3 ml chloroform-methanol (1:2 vol/vol), 0.2 ml chloroform, and 0.2 ml water. The resultant organic phase was dried under N 2 and reconstituted in 25 l of chloroform/ methanol (95:5 vol/vol). The samples were spotted onto a Silica Gel 60 TLC plate being heat activated and developed in a solvent mixture of chloroform-acetone-methanol-acetic acid-water (10:4:3:2:1 vol/vol/vol/vol/vol). Because DAG kinase can use ceramide or DAG as a substrate, [ 32 P]ceramidephosphate represented ceramide production and [
32 P]phosphatidic acid represented DAG production (34) . The TLC plates were exposed to phosphor screens for 18 h, and [
32 P]ceramide-phosphate and [
32 P]phosphatidic acid were quantified using the Molecular Dynamics System ImageQuaNT computer software. Results are expressed as percentage of control.
Western blot analysis. Cells were cultured in serum-free medium for 16 h and then treated with experimental compounds for 30 min. The cells were washed twice with ice-cold PBS and extracted with 100 l of RIPA-L buffer [10 mM Tris (pH 8), 1.5 mM MgCl 2, 5 mM KCl, 0.5 mM DTT, 0.5 mM phenylmethylsulfonyl fluoride, 1% Nonidet P-40, 0.1% SDS, 0.5% sodium deoxycholate, and 5 g/ml leupeptin]. Samples were frozen on dry ice/ethanol and stored at Ϫ80°C. Samples were sonicated 10-15 s, heated at 95°C for 5 min, centrifuged, and 40 l/sample were loaded onto SDS-PAGE gel and electrotransferred to nitrocellulose membrane. The membrane was blocked (1 h at room temperature) and probed with primary antibody (1:1,000 overnight at 4°C). It was washed in TBST, incubated with horseradish peroxidase (HRP)-conjugated secondary antibody (1:2,000) and HRPconjugated anti-biotin antibody (1:1,000) to detect biotinylated protein markers (2 h at room temperature), washed, incubated with LumiGLO (1 min), and exposed to X-ray film. Densitometric quantitation was done using the UN-SCAN-IT program (Silk Scientific, UT), and data were normalized to control.
Statistical analysis. The data were analyzed by repeated measure using ANOVA for each set of experiments. The data are presented as means Ϯ SE. of at least three independent experiments. Differences of P Ͻ 0.05 were considered statistically significant. The percent inhibition data was analyzed with repeated measure using ANOVA, and the data from G␣-PTX expressing clones were compared with Balb-D2S cell (wild type) using Bonferroni multiple comparison posttest.
RESULTS
Apomorphine-induce DAG and ceramide production in Balb-D2S cells.
In Balb/c-3T3 cells stably transfected with the dopamine-D2S receptor (Balb-D2S cells), DAG and ceramide production was induced by apomorphine (dopamine receptor agonist) in a concentration-dependent manner with EC 50 of 10 Ϫ8 M (Fig.  1) . Within 30 min, apomorphine (10 Ϫ5 M) increased DAG and ceramide compared with control levels by 400% (500 pmol/10 7 cells) and 300% (430 pmol/10 to form ceramide and also increased DAG formation, suggesting conversion of ceramide to DAG. The bands of radioactive DAG and ceramide comigrated with DAG and ceramide standards and were quantified in the concentration range from 50-1,000 pmol. Apomorphine-induced DAG and ceramide production was time dependent (Fig. 2 ) and maximal at 1 and 6 h, respectively. Ceramide production returned to basal at 24 h, whereas DAG was elevated at 30 h. Apomorphineinduced DAG paralleled and was greater than the increase in ceramide production. Pretreatment with PTX blocked DAG and ceramide formation induced by 10 Ϫ6 M apomorphine (Fig. 3) , thus implicating G i /G o proteins in D2S receptor action. As a positive control, exogenous SMase increased the levels of ceramide equally in cells treated or not treated with PTX (Fig.  3B) , demonstrating G protein-independent hydrolysis of endogenous SM to form ceramide.
G␣ i2 -and G␣ i3 -PTX fail to rescue apomorphine-induced DAG and ceramide formation. Balb-D2S cells express all G␣ i/o -subunits, although G␣ i2 and G␣ i3 appear to be the most abundant based on densitometric analysis (16) . To address the G protein specificity of D2S signaling to ceramide production, PTX-insensitive point mutants of G␣ i2 and G␣ i3 (G␣ i2 -PTX and G␣ i3 -PTX) were transfected into Balb-D2S cells to form G␣ i2 -PTX (BDi2-22) cells and G␣ i3 -PTX (BDi3-3) cells. The transfectant cell lines expressed twofold more G␣ protein than the corresponding endogenous G␣-subunit in parental Balb-D2S (16), suggesting that approximately equal amounts of mutant and wild-type protein were produced in the transfected cell lines. In G␣ i2 -PTX (BDi2-22) and G␣ i3 -PTX (BDi3-3) cells, apomorphine-induced DAG and ceramide formation 32 P]phosphatidic acid is shown. Standards for ceramide only were used at the indicated amounts. The relative levels (% control) of DAG and ceramide were quantified and plotted as a function of time. Data are expressed as means Ϯ SE from 3 independent experiments. *P Ͻ 0.05; **P Ͻ 0.03; ***P Ͻ 0.01. Cer, ceramide.
was blocked after pretreatment with PTX (Figs. 4 and  5) , suggesting that G i2 or G i3 alone do not mediate D2S-induced ceramide production. By contrast, apomorphine-induced inhibition of cAMP formation was rescued in both G␣ i2 -and G␣ i3 -PTX cells (16) . As a positive control, exogenous SMase (0.1 U/ml) induced ceramide production. Hence, neither G␣ i2 -PTX or G␣ i3 -PTX rescued D2S receptor coupling to DAG and ceramide production after PTX treatment.
GRK-ct blocks apomorphine-induced DAG and ceramide formation. We examined whether G␤␥-subunits are involved in D2S-induced DAG and ceramide production in stably transfection of Balb-D2S cells with GRK-ct, a scavenger protein that binds to G␤␥-subunits to prevent their action. In these cells, apomorphine did not alter ceramide production, but exogenous SMase (0.1 U/ml) did induce ceramide production (Fig.  6) . Importantly, other D2S-induced actions, such as inhibition of forskolin-induced cAMP accumulation, were not affected by expression of GRK-ct in these cells (16) , indicating that functional D2S receptors were present in these clones. This result suggests a crucial role for mobilization of G␤␥-subunits in the D2S-mediated ceramide signal. 
Role of phospholipase C in D2S-induced formation of DAG/ceramide.
According to the results above, we further investigated upstream of DAG/ceramide formation by the action of apomorphine in Balb-D2S cells (Fig. 7) . Phospholipase C inhibitors U-73122 (10 Ϫ5 M, U) for phosphatidylinositol (PI)-PLC and D609 (10 (Fig. 8) . These results are consistent with a specific role for PLC activation in D2S-induced DAG and ceramide formation.
Regulation of ERK1/2 by ceramide. The possible downstream actions of ceramide were examined by comparing the actions of apomorphine, ceramide analog C2-ceramide, and SMase on mitogen-activated protein kinases in Balb-D2S cells (Fig. 9) . Antibodies specific for phosphorylated forms that represent activated proteins were used in Western blot analysis. In other cell types, ceramide activates stress-activated protein kinases, such as p38 or JNK, to mediate apoptosis (2, 6, 41), so we examined these pathways. Neither dopamine agonist (apomorphine), C2-ceramide, nor SMase altered levels of phospho-p38 (Fig. 9) , phospho-STAT3, or phospho-STAT5 (not shown) compared with control as assessed by densitometry. As previously reported (16), apomorphine induced a 2.2-fold increase in phospho-ERK1/2. In addition, C 2 -ceramide and SMase also induced a 2.1-and 2.0-fold,, respectively, increase in phospho-ERK1/2. By contrast, whereas apomorphine induced a small (1.5-fold) increase in phospho-JNK, this was not mimicked by C 2 -ceramide or SMase treatment. Thus ceramide appears to specifically regulate ERK1/2 phosphorylation in Balb-D2S cells, providing a novel potential mechanism for dopamine D2S-induced ERK1/2 activation.
DISCUSSION
D2S-induced DAG and ceramide formation.
In Balb/ c-3T3 cells expressing D2S receptors, apomorphine in- duced DAG and ceramide formation in a concentrationand time-dependent manner and was blocked by PTX, implicating G i /G o proteins. The D2S receptor provides a novel and interesting example of a G i /G o -coupled receptor that induces DAG and ceramide formation with the same G protein specificity: these actions were dependent on G␤␥-subunits but were not rescued by individual G␣ i2 -or G␣ i3 -PTX subunits (see model, Fig. 10 ). Other receptor subtypes such as the angiotensin II type 2 (AT2) receptor (21) or interferon-␥ receptor (42) mediate PTX-sensitive ceramide production, but their G protein specificity has not been examined. The G i -coupled cannabinoid CB1 receptor also induces ceramide formation to inhibit tumor growth (14) , but it is unclear whether this is a G i /G o -mediated action.
The matching apomorphine concentration dependencies (EC 50 ϭ 10 Ϫ8 M), PLC inhibitor concentration dependencies, G protein subunit dependencies, and the close temporal association between D2S-induced DAG and ceramide formation suggest that DAG formed by D2S-induced PLC activation is converted to ceramide as shown in Fig. 10 . The differential action PLC inhibitor (U73,122 selective for PI-PLC stronger than D609 for PC-PLC) further indicates the primary role of PI-PLC in D2S-induced DAG and ceramide generation. Interconversion of DAG and ceramide could be catalyzed by SM synthase, which converts ceramide and PC into SM and DAG (22) . In cells, this reaction is bidirectional and can convert DAG into ceramide, leading to depletion of SM (25, 40) . Importantly, DAG inhibits the forward reaction to favor conversion to ceramide (18, 43) . Ceramide inhibits de novo synthesis of PC (43) , again favoring the reverse reaction to form ceramide from DAG. D609, a compound thought to be specific for PC-PLC but that also inhibits SM synthase (25) , displayed slightly greater inhibition of ceramide than of DAG (60 vs. 50%), suggesting at best a partial role for SMase in DAG-ceramide conversion. Alternately, DAG can activate acidic SMase to generate ceramide (35, 36) . For example, tumor necrosis factor couples to PC-PLC to increase production of DAG, which activates acidic SMase to induce ceramide production. The conversion of DAG to ceramide or DAGinduced ceramide formation would account for the identical G␣ and G␤␥ dependencies of D2S-mediated DAG and ceramide formation.
G protein specificity of D2S responses. There are striking similarities between the pattern of G protein subunits required for D2S-induced DAG/ceramide formation and calcium mobilization in Balb-D2S or L-D2S cells: G␤␥-subunits were required and no individual or pair of G␣-PTX proteins reconstituted D2S-induced calcium mobilization (15, 16) . Receptor-mediated activation of PI-PLC is known to generate IP3, which mediates calcium mobilization and DAG (3, 4) , an important second messenger that activates PKC (30) . Thus the D2S receptor mediates G␤␥-dependent calcium mobilization and DAG formation, possibly by activation of PI-PLC-␤2 or -␤3, which are G␤␥ sensitive. D2S-induced DAG appears to be rapidly converted to increase ceramide levels (Fig. 10) . The lack of rescue Fig. 9 . Regulation of mitogen-activated protein kinases by apomorphine and ceramide. Balb-D2S cells were treated without (control, C) or with apomorphine (10 Ϫ7 M), dopamine (10 Ϫ7 M, D), C2-ceramide (5 M, C2), inactive analog dihydro-C2-ceramide (5 M, D2-C2), or SMase (0.1 U/ml) for 30 min. After harvesting cells, Western immunoblotting using antibodies to the indicated phospho-protein or ␤-actin (loading control) was carried out. At top are shown representative blots, and at bottom is densitometric quantitation of data (means Ϯ SE) from 3 independent experiments expressed as %control for phospho-JNK (left) and phospho-ERK1/2 (right). *P Ͻ 0.05; **P Ͻ 0.01. Fig. 10 . D2S receptor-mediated signaling pathways in Balb/c-3T3 cells. The D2S receptor signals through PTX-sensitive Gi/Go proteins to mobilize G␣i-and G␤␥-subunits. Previous studies showed that D2S-induced inhibition of adenylyl cyclase (AC) involved G␣i2-or G␣i3-but not G␤␥-subunits (16) . G␤␥-subunits were essential for D2S-induced IP3-mediated calcium mobilization (Ca 2ϩ ), DAG [which activates protein kinase C (PKC)], and ceramide formation. G␤␥-dependent phospholipase C (PI-PLC more than PC-PLC) mediates this novel pathway as assessed by inhibitors U-73122 and D609. Both G␤␥ and, in part, G␣i2 were required for D2S-induced ERK1/2 activation and DNA synthesis (16) . Ceramide induces ERK1/2 activation, suggesting that G␤␥-dependent ceramide formation represents a novel pathway of D2S-induced ERK1/2 activation leading to cell growth. Note that arrows indicate stimulation, bars indicate inhibition; solid lines denote direct effects, whereas dashed lines are indirect or multistep pathways. of these responses by individual (or paired) G␣-PTX proteins could indicate that activation of G i1 , G o , or multiple G proteins is required to mobilize sufficient G␤␥-subunits. However, the possibility remains that PTX-insensitive G␣-subunits may couple inefficiently to this response because of the Cys-to-Ser change. By contrast, D2S-induced inhibition of forskolin-stimulated cAMP formation was rescued by G␣ i2 -or G␣ i3 -PTX, indicating their functionality in these cells (16) .
Role of D2S-induced DAG or ceramide formation in ERK1/2 activation. As illustrated in Fig. 10 , in Balb-D2S cells apomorphine-induced ERK1/2 activation and DNA synthesis are blocked by PTX and GRK-ct and are rescued by G␣ i2 -PTX but not G␣ i3 -or G␣ o -PTX, implicating G␣ i2 , G␤␥, and ERK1/2 in cell growth (16) . In the present study, D2S-induced ERK1/2 activation was mimicked by ceramide analog or SMase-mediated ceramide generation, suggesting that D2S-induced ceramide formation mediates in part ERK1/2 phosphorylation. Although G i2 -PTX did rescue D2S-induced ERK1/2 activation and cell growth, the rescue was only partial (16) , suggesting that G i2 -dependent and -independent pathways may contribute. One G i2 -independent, G␤␥-dependent pathway activated by D2S receptors may involve ceramide formation. It is possible that G␣ i1 or G␣ o couple D2S receptors to DAG or ceramide formation. G␣ i1 appears to couple to growth regulatory signaling, because G␣ i1 -PTX clones became spontaneously transformed but were therefore weakly responsive to apomorphine and were not examined. These studies illustrate the utility of PTX-insensitive G proteins as a molecular approach to map G protein-mediated pathways and to place novel second messengers such as ceramide within these pathways.
